ViGuard Health Petitions FDA to Classify IND as a Supplement

Drug Industry Daily
A A
ViGuard Health called on the FDA to declare pyridoxamine to be a dietary supplement and no longer authorized for investigation as a new drug.

To View This Article:

Login

Subscribe To Drug Industry Daily